Post-mortem human brain immunohistochemical staining also confirmed that compared to control individuals, patients with AD have a significant increase in the expression of FMNL2 near the glial endfeet at the blood vessels and in astrocytes that appear hypertrophic and reactive. Here, FMNL2 is linked to Alzheimer disease.